Results 11 to 20 of about 861 (215)
Novel drug development for neuromuscular blockade
Pharmacological advances in anesthesia in recent decades have resulted in safer practice and better outcomes. These advances include improvement in anesthesia drugs with regard to efficacy and safety profiles.
Amit Prabhakar +5 more
doaj +1 more source
Neuromuscular block in patients 80 years and older: a prospective, controlled study
Background An increasing number of patients older than 80 years are undergoing anesthesia, but little information is available regarding pharmacodynamic effects of myorelaxants in this population.
Denis Schmartz +4 more
doaj +1 more source
National survey on the use of neuromuscular blockers and reversal in adult, pediatric and pregnant patients. [PDF]
Introduction This study presents the findings of an Italian investiga- tion through SIAATIP - Italian Society of Anesthesia, Analgesia and Pediatric Intensive Care - aimed at gather- ing data on current anesthetic practices related to the use of ...
A. Federici +9 more
doaj +1 more source
Deep Neuromuscular Blockade During General Anesthesia: Advantages, Challenges, and Future Directions
Background: Neuromuscular blocking agents play an important role in modern anesthesia by facilitating optimal surgical conditions through deep muscle relaxation.
Jacob Rosenberg, Thomas Fuchs-Buder
doaj +1 more source
Reversal agents in anaesthesia and critical care
Despite the advent of short and ultra-short acting drugs, an in-depth knowledge of the reversal agents used is a necessity for any anaesthesiologist.
Nibedita Pani +2 more
doaj +1 more source
Critical Care Nurses' Performance Regarding Use of Neuromuscular Blocking Agents in Patients with Respiratory Failure [PDF]
:Background: The respiratory system provides oxygen to and removes carbon dioxide from the body however the inability to perform either or both of these tasks results in respiratory failure. Aim: The present study aimed to assess the critical care nurses'
Shimaa Ali +2 more
doaj +1 more source
Background: Quantitative train-of-four (TOF) monitoring remains essential in optimizing anesthetic outcomes by assessing the depth and recovery from neuromuscular blockade. Despite this, residual neuromuscular blockade, defined as a TOF ratio
Kwaku Owusu-Bediako +3 more
doaj +1 more source
Newer Neuromuscular Blocking Agents [PDF]
Four neuromuscular blocking drugs, doxacurium, mivacurium, pipecuronium, and rocuronium have been or are about to be introduced into clinical practice. The purpose of this MiniReview is to describe their pharmacology, to consider their place in clinical anaesthetic practice, and to examine whether the needs of the clinican have been met.
openaire +2 more sources
Background: Neuromuscular blocking agents may improve outcomes in specific conditions, including the early phase of acute respiratory distress syndrome.
Bertrand Hermann +37 more
doaj +1 more source
Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs
Background: Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general anaesthesia and postoperative residual ...
Kamilla Pedersen +3 more
doaj +1 more source

